ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Livostin Nasenspray, Suspension - 10 ml
50497011 JNTL Consumer Health II (Switzerland) GmbH
Livostin Nasenspray, Suspension27.06.1994
  27.06.1994
Levocabastine (R01AC02)12.12.2003
WHO-DDD 
12.02.70.10 ml
12.02.70. 
D  
No 
IPCI
8.46  
k.A.15.60
  
7680504970110Synthetika
  
Composition
levocabastinum 0.5 mg ut levocabastini hydrochloridum corresp. levocabastinum 0.05 mg pro dosi, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, hypromellosum, polysorbatum 80, dinatrii edetas, propylenglycolum, benzalkonii chloridum 0.15 mg, aqua purificata ad suspensionem pro 1 ml, doses pro vase 86.
Packungsbestandteile
Suspension
 
 
Active AgentDose
Levocabastine0.5 mg/ml
 
Inactive agentsDose
Benzalkonium Chloride0.15 mg/ml
Dinatrii Edetas 
Disodium Phosphate 
Hypromellosum 
Sodium Dihydrogenophosphate Monohydrate 
Polysorbatum 80 
Propylenglycol 
Source
Data was imported : 07.01.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home